| TCMI01220 |
(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2E)-6-methylhepta-2,5-dien-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol |
C42H70O13 |
| TCMI01263 |
(3S,9S,10S,13R,14S,17S)-17-[(E,2S,5S)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol |
C28H46O |
| TCMI01354 |
(2E)-1-[2,4-Dihydroxy-3-[(2S)-2,3-dihydroxy-3-methylbutyl]-6-methoxyphenyl]-3-(4-hydroxyphenyl)-2-propene-1-one |
C21H24O7 |
| TCMI01762 |
Galbelgin |
C22H28O5 |
| TCMI02198 |
(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(1S,5S)-5-hydroxy-4-methyl-1-propan-2-ylcyclohex-3-en-1-yl]oxyoxane-3,4,5-triol |
C16H28O7 |
